Page last updated: 2024-09-05

bw a522 and n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine

bw a522 has been researched along with n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine in 4 studies

Compound Research Comparison

Studies
(bw a522)
Trials
(bw a522)
Recent Studies (post-2010)
(bw a522)
Studies
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)
Trials
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)
Recent Studies (post-2010) (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)
1000214558

Protein Interaction Comparison

ProteinTaxonomybw a522 (IC50)n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine (IC50)
high affinity choline transporter 1 isoform aHomo sapiens (human)2.1002
Adenosine receptor A3Homo sapiens (human)0.0017

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Figler, H; Jin, X; Linden, J; Robeva, AS; Thai, T1
Jones, CA; Reeves, JJ; Sheehan, MJ; Vardey, CJ; Whelan, CJ1
Auchampach, JA; Caughey, GH; Jin, X; Linden, J; Wan, TC1
Bril, A; Broadley, KJ; Gardner, NM; Khandoudi, N; Maddock, HL1

Other Studies

4 other study(ies) available for bw a522 and n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine

ArticleYear
Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells.
    Molecular pharmacology, 1999, Volume: 56, Issue:4

    Topics: Animals; Anti-Asthmatic Agents; Blotting, Western; Calcium; Cell Degranulation; Cells, Cultured; CHO Cells; Cricetinae; Cyclic AMP; GTP-Binding Proteins; Humans; Kidney; Mast Cells; Purinergic P1 Receptor Agonists; Radioligand Assay; Receptor, Adenosine A2B; Receptors, Purinergic P1; Theophylline; Type C Phospholipases; Xanthines

1999
Adenosine A3 receptors promote degranulation of rat mast cells both in vitro and in vivo.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1997, Volume: 46, Issue:5

    Topics: Adenosine; Administration, Cutaneous; Animals; Blood Proteins; Cell Degranulation; Cyproheptadine; Dinitrophenols; Female; Humans; In Vitro Techniques; Injections, Intravenous; Male; Mast Cells; Mice; p-Methoxy-N-methylphenethylamine; Pleura; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Rats, Wistar; Receptors, Purinergic P1; Serotonin; Serotonin Antagonists; Serum Albumin; Skin; Theophylline; Triazoles; Xanthines

1997
Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor.
    Molecular pharmacology, 1997, Volume: 52, Issue:5

    Topics: Adenine; Adenosine; Amino Acid Sequence; Animals; Base Sequence; beta-N-Acetylhexosaminidases; Calcium; Chlorocebus aethiops; COS Cells; Dinucleoside Phosphates; DNA, Complementary; Dogs; Mast Cells; Mast-Cell Sarcoma; Molecular Sequence Data; Neoplasm Proteins; Norbornanes; Receptor, Adenosine A3; Receptors, Purinergic P1; RNA, Messenger; Sequence Alignment; Sequence Homology, Amino Acid; Xanthines

1997
Protection from myocardial stunning by ischaemia and hypoxia with the adenosine A3 receptor agonist, IB-MECA.
    European journal of pharmacology, 2003, Sep-23, Volume: 477, Issue:3

    Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Coronary Circulation; Endothelium, Vascular; Guinea Pigs; Heart Atria; Hypoxia; Male; Myocardial Ischemia; Myocardial Stunning; Oxygen; Papillary Muscles; Perfusion; Receptor, Adenosine A3; Reperfusion Injury; Time Factors; Xanthines

2003